Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study
Cross-sectional study
Point-of-Care Testing
DOI:
10.1186/s12916-022-02603-x
Publication Date:
2022-10-24T13:03:48Z
AUTHORS (18)
ABSTRACT
Abstract Background The diagnostic accuracy of unsupervised self-testing with rapid antigen tests (Ag-RDTs) is mostly unknown. We studied the a self-performed SARS-CoV-2 saliva and nasal Ag-RDT in general population. Methods This large cross-sectional study consecutively included unselected individuals aged $$\ge$$ <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:mo>≥</mml:mo> </mml:math> 16 years presenting for testing at three public health service test sites. Participants underwent molecular sampling received two self-tests (the Hangzhou AllTest Biotech self-test SD Biosensor by Roche Diagnostics) to perform themselves home. Diagnostic both was assessed as reference. Results Out 2819 participants, 6.5% had positive test. Overall sensitivities were 46.7% (39.3–54.2%) 68.9% (61.6–75.6%) Ag-RDT. With viral load cut-off (≥ 5.2 log10 E-gene copies/mL) proxy infectiousness, these increased 54.9% (46.4–63.3%) 83.9% (76.9–89.5%), respectively. For Ag-RDT, 78.5% (71.1–84.8%) 22.6% (9.6–41.1%) those symptomatic asymptomatic time sampling, which 90.4% (83.8–94.9%) 38.9% (17.3–64.3%) after applying cut-off. In without prior infection, 36.8% (16.3–61.6%) 72.7% (65.1–79.4%). Specificities > 99% 99%, predictive values 70% 90%, negative 95% 95%, respectively, most analyses. Most participants considered self-performing result interpretation (very) easy self-tests. Conclusions self not reliable detection, overall, all subgroups. high sensitivity symptoms infection but low warrants further investigation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (17)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....